These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Suppression of Myocardial 18F-FDG Uptake Through Prolonged High-Fat, High-Protein, and Very-Low-Carbohydrate Diet Before FDG-PET/CT for Evaluation of Patients With Suspected Cardiac Sarcoidosis. Lu Y, Grant C, Xie K, Sweiss NJ. Clin Nucl Med; 2017 Feb; 42(2):88-94. PubMed ID: 27922863 [Abstract] [Full Text] [Related]
35. 18F-FDG PET/CT, 99mTc-MIBI, and MRI in the prediction of outcome of patients with multiple myeloma: a comparative study. Fonti R, Pace L, Cerchione C, Catalano L, Salvatore B, De Luca S, Pane F, Salvatore M, Del Vecchio S. Clin Nucl Med; 2015 Apr; 40(4):303-8. PubMed ID: 25608167 [Abstract] [Full Text] [Related]
36. Somatostatin receptor based PET/CT in patients with the suspicion of cardiac sarcoidosis: an initial comparison to cardiac MRI. Lapa C, Reiter T, Kircher M, Schirbel A, Werner RA, Pelzer T, Pizarro C, Skowasch D, Thomas L, Schlesinger-Irsch U, Thomas D, Bundschuh RA, Bauer WR, Gärtner FC. Oncotarget; 2016 Nov 22; 7(47):77807-77814. PubMed ID: 27780922 [Abstract] [Full Text] [Related]
38. The Utility of Whole Body 18F-FDG PET-CT in Diagnosing Isolated Cardiac Sarcoidosis: The Western Australian Cardiac Sarcoid Study. Giudicatti L, Marangou J, Nolan D, Dembo L, Baumwol J, Dwivedi G. Heart Lung Circ; 2020 Jan 22; 29(1):e1-e6. PubMed ID: 31501049 [Abstract] [Full Text] [Related]